When Vas Narasimhan started as the new CEO of the Swiss drug giant Novartis, he began refocusing the company on a key business area: prescription medicines. Until recently, alongside top-selling ...

Narasimhan, a trained physician and former McKinsey consultant, has plotted his career to have the largest possible impact on public health. Now at Novartis, the giant Swiss pharmaceutical company ...

Novartis CEO Vas Narasimhan outlined projections for the company's future at the 2025 JP Morgan Healthcare conference in San Francisco on 14 January. Novartis, he said, expects peak sales of over ...